Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
30M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
1.2M
-
Shares change
-
-214K
-
Total reported value, excl. options
-
$1.99M
-
Value change
-
-$409K
-
Put/Call ratio
-
1.19
-
Number of buys
-
11
-
Number of sells
-
-6
-
Price
-
$1.65
Significant Holders of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) as of Q2 2022
29 filings reported holding EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share as of Q2 2022.
EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.2M shares
of 30M outstanding shares and own 4.01% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (441K shares), ESSEX INVESTMENT MANAGEMENT CO LLC (168K shares), SABBY MANAGEMENT, LLC (142K shares), GEODE CAPITAL MANAGEMENT, LLC (108K shares), BlackRock Inc. (73.9K shares), RENAISSANCE TECHNOLOGIES LLC (44.6K shares), Strategic Wealth Investment Group, LLC (30.4K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (29.6K shares), Compagnie Lombard Odier SCmA (25K shares), and CITADEL ADVISORS LLC (24.9K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.